Literature DB >> 28740686

Whole lung lavage-technical details, challenges and management of complications.

Ahmed Awab1, Muhammad S Khan1, Houssein A Youness1.   

Abstract

Pulmonary alveolar proteinosis (PAP) is a rare disease characterized by alveolar accumulation of surfactant material with resulting hypoxemia and reduced lung function. Whole lung lavage (WLL) to physically remove the proteinaceous material from the affected lung is the standard treatment. Since its original description in 1964, there have been increasing numbers of WLL procedures done worldwide and the technique has been variously refined and modified. When done in experienced centers, WLL provides long lasting benefit in the majority of patients. It is considered safe and effective. There are no guidelines standardizing the procedure. Our preferred method is to lavage one lung at a time, with the patient supine, filling to functional residual capacity (FRC) and repeating cycles of drainage and instillation with chest percussion until the effluent is clear. The aim of this article is to provide a detailed description of the technique, equipment needed and logistic considerations as well as providing a physiologic rationale for each step of WLL. We will also review the available data concerning variations of the technique described in the literature.

Entities:  

Keywords:  Pulmonary alveolar proteinosis (PAP); rare disease; whole lung lavage (WLL)

Year:  2017        PMID: 28740686      PMCID: PMC5506114          DOI: 10.21037/jtd.2017.04.10

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  36 in total

1.  Pulmonary alveolar proteinosis. A review of the findings and theories to date, with a digression on Pneumocystis carinii pneumonia.

Authors:  P N DE SANCTIS
Journal:  BMQ       Date:  1962-03

2.  British Thoracic Society guideline for diagnostic flexible bronchoscopy in adults: accredited by NICE.

Authors:  I A Du Rand; J Blaikley; R Booton; N Chaudhuri; V Gupta; S Khalid; S Mandal; J Martin; J Mills; N Navani; N M Rahman; J M Wrightson; M Munavvar
Journal:  Thorax       Date:  2013-08       Impact factor: 9.139

Review 3.  Pulmonary alveolar proteinosis.

Authors:  J M Davidson; W M Macleod
Journal:  Br J Dis Chest       Date:  1969-01

4.  Pulmonary alveolar proteinosis causing severe hypoxemic respiratory failure treated with sequential whole-lung lavage utilizing venovenous extracorporeal membrane oxygenation: a case report and review.

Authors:  E S Cohen; E Elpern; M R Silver
Journal:  Chest       Date:  2001-09       Impact factor: 9.410

Review 5.  Update on the clinical diagnosis, management, and pathogenesis of pulmonary alveolar proteinosis (phospholipidosis).

Authors:  W D Claypool; R M Rogers; G M Matuschak
Journal:  Chest       Date:  1984-04       Impact factor: 9.410

6.  Venovenous bypass with a membrane lung to support bilateral lung lavage.

Authors:  W M Zapol; R Wilson; C Hales; D Fish; G Castorena; A Hilgenberg; D Quinn; R Kradin
Journal:  JAMA       Date:  1984 Jun 22-29       Impact factor: 56.272

7.  Advances in the treatment of pulmonary alveolar proteinosis.

Authors:  D Kao; K Wasserman; D Costley; J R Benfield
Journal:  Am Rev Respir Dis       Date:  1975-03

8.  [Effect of positive end expiratory pressure on arterial oxygenation during bronchoalveolar lavage for proteinosis].

Authors:  T Julien; M Caudine; H Barlet; P Wintrebert; P Aubas; J du Cailar
Journal:  Ann Fr Anesth Reanim       Date:  1986

9.  Alveolar proteinosis lung lavage using partial cardiopulmonary bypass.

Authors:  A P Freedman; A Pelias; R F Johnston; I P Goel; H I Hakki; T Oslick; J P Shinnick
Journal:  Thorax       Date:  1981-07       Impact factor: 9.139

10.  Whole-lung lavage in alveolar proteinosis by a modified lavage technique.

Authors:  R Bingisser; V Kaplan; A Zollinger; E W Russi
Journal:  Chest       Date:  1998-06       Impact factor: 9.410

View more
  16 in total

1.  Novel method of noninvasive ventilation supported therapeutic lavage in pulmonary alveolar proteinosis proves to relieve dyspnea, normalize pulmonary function test results and recover exercise capacity: a short communication.

Authors:  Szymon Skoczynski; Katarzyna Wyskida; Patrycja Rzepka-Wrona; Magdalena Wyskida; Ewa Uszok-Gawel; Dawid Bartocha; Lukasz Krzych; Wladysław Pierzchala; Adam Barczyk
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

Review 2.  Inhalation Injury in the Burned Patient.

Authors:  Guillermo Foncerrada; Derek M Culnan; Karel D Capek; Sagrario González-Trejo; Janos Cambiaso-Daniel; Lee C Woodson; David N Herndon; Celeste C Finnerty; Jong O Lee
Journal:  Ann Plast Surg       Date:  2018-03       Impact factor: 1.539

3.  How We Do It: Whole Lung Lavage.

Authors:  Deepa Shrestha; Sahajal Dhooria; Ganesh Kumar Munirathinam; Inderpaul Singh Sehgal; Kuruswamy Thurai Prasad; Babu Ram; Harkant Singh; Ashutosh N Aggarwal; Goverdhan D Puri; Valliappan Muthu; Ritesh Agarwal
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2022-06-29       Impact factor: 1.803

4.  A case of autoimmune pulmonary alveolar proteinosis with severe respiratory failure treated with segmental lung lavage and oral statin therapy.

Authors:  Tomotsugu Takano; Keisuke Takeda; Satoshi Nakamura; Genta Akiyama; Nobuhisa Ando; Masashi Komori
Journal:  Respir Med Case Rep       Date:  2022-06-06

5.  Inhaled granulocyte-macrophage colony stimulating factor for mild-to-moderate autoimmune pulmonary alveolar proteinosis - a six month phase II randomized study with 24 months of follow-up.

Authors:  Xinlun Tian; Yanli Yang; Lulu Chen; Xin Sui; Wenshuai Xu; Xue Li; Xiaobei Guo; Lingshan Liu; Yusen Situ; Jun Wang; Yang Zhao; Shuzhen Meng; Wei Song; Yonglong Xiao; Kai-Feng Xu
Journal:  Orphanet J Rare Dis       Date:  2020-07-02       Impact factor: 4.123

6.  Better approach for autoimmune pulmonary alveolar proteinosis treatment: inhaled or subcutaneous granulocyte-macrophage colony-stimulating factor: a meta-analyses.

Authors:  Gaohong Sheng; Peng Chen; Yanqiu Wei; Jiaojiao Chu; Xiaolei Cao; Hui-Lan Zhang
Journal:  Respir Res       Date:  2018-08-31

7.  The effectiveness of N-acetylcysteine for an adult case of pulmonary alveolar proteinosis: A case report.

Authors:  Haiyan Zhang
Journal:  Respir Med Case Rep       Date:  2019-06-14

8.  Autoimmune pulmonary alveolar proteinosis in an adolescent successfully treated with inhaled rhGM-CSF (molgramostim).

Authors:  Marta E Gajewska; Sajitha S Sritharan; Eric Santoni-Rugiu; Elisabeth M Bendstrup
Journal:  Respir Med Case Rep       Date:  2018-02-23

9.  Removal of lung lavage fluid during whole-lung lavage using biphasic cuirass ventilation chest percussion in a patient with autoimmune pulmonary alveolar proteinosis.

Authors:  Kei Nakamura; Satoko Omura; Koichiro Kajiura; Masanobu Ishigaki
Journal:  Lung India       Date:  2019 Nov-Dec

10.  Severe pulmonary alveolar proteinosis with respiratory failure treated by intrapulmonary percussive ventilation.

Authors:  Takahiro Tashiro; Yusuke Tomita; Megumi Inaba; Kumiko Hayashi; Naomi Hirata; Takuro Sakagami
Journal:  Respirol Case Rep       Date:  2020-11-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.